This article and associated images are based on a poster originally authored by Marisa Amato and presented at ELRIG Drug Discovery 2025 in affiliation with Singleron Biotechnologies GmbH. This poster ...

RNAConnect, developer of enzymatic tools for visualizing and manipulating RNA, today announced the release of the UltraMarathonRT ® Two-Step RT-qPCR Kit, a next-generation tool for RNA researchers ...

A new approach using RNA instead of DNA has improved the accuracy of liquid biopsy tests for early-stage colorectal cancer, according to a study by researchers at the University of Chicago. The method ...

Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "RNA Analysis / Transcriptomics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for RNA ...

The Global RNA Therapeutics Market is valued at USD 10.9 Billion in 2024 and is projected to attain a value of USD 29.6 Billion by 2035 at a CAGR of 9.55% during the forecast period 2025-2035. The RNA ...

STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration ...